Screening
Aimed at the cervical screening market, this device will provide real time scientific diagnosis at the point-of-care. It will also reduce the significant traffic in the healthcare system between primary care, cytology laboratories and colposcopy clinics, resulting in a more effective application of healthcare resources.
Key Benefits
- Greater accuracy in differentiating between cervical neoplasia and ambiguous abnormalities
- “Real time” diagnosis
- Reduction in number of referrals to colposcopy clinics
Features
- Disposable sleeve – replaced for each patient
- Wipe-clean surfaces – suitable for examination rooms
- Wireless operation
- On-board user interface – for ease of operation
- Ergonomic design
- Built-in QC tests
- PC interface for diagnostic analysis
Clinical Trials
Zilico is establishing a detailed performance specification and clinical trial protocol for the screening device in consultation with opinion leaders in the UK and Europe.